Trajectories of brain change in psychosis: ‘risk’ or ‘resilience’?

When:
January 25, 2018 @ 6:00 pm – 7:00 pm
2018-01-25T18:00:00+00:00
2018-01-25T19:00:00+00:00
Where:
Wolfson Lecture Theatre
16 De Crespigny Park
Camberwell, London SE5 8AF
UK
Cost:
Free
Contact:

The Paul Janssen Lecture has been a regular feature of the academic calendar at the Institute of Psychiatry, Psychology & Neuroscience for nearly 20 years.

Lecturers are chosen on the basis of their global eminence in the field of neuroscience with a focus on schizophrenia. The annual lecture is named in honour of Belgian pharmacologist Paul Janssen (1926–2003) noted for discovering various drugs important to psychiatry, such as haloperidol, and who founded Janssen – the pharmaceutical company which sponsors the event.

This is a free event. Places are allocated on a first come first served basis and booking is essential.

Professor Christos Pantelis is an NHMRC Senior Principal Research Fellow, Foundation Professor of Neuropsychiatry and Scientific Director of the Melbourne Neuropsychiatry Centre at The University of Melbourne and Melbourne Health. He holds an Honorary Professorial Fellow position at the Florey Institute for Neuroscience & Mental Health and heads the Adult Mental Health Rehabilitation Unit at Sunshine Hospital. He is an Honorary Adjunct Professor in the Centre for Neural Engineering (CfNE), Department of Electrical and Electronic Engineering at University of Melbourne.

He leads a team of over 60 clinical and research scientists and students that have been undertaking neuroimaging and neuropsychological work in schizophrenia and psychosis, and other psychiatric and neurodegenerative disorders since 1993 in Australia. His work has focused on brain structural and functional changes during the transition to psychosis. His group was the first to describe progressive brain structural changes at psychosis onset, with a seminal paper published in The Lancet in 2003.

Professor Christos Pantelis has established a unique resource of over 5,000 multimodal brain scans in patients with schizophrenia and other neuropsychiatric disorders, including longitudinal imaging. Recent work focuses on early developmental disorders, including children with schizotypal features and autism.

He was named in the Thomson Reuters list of “The World’s Most Influential Scientific Minds” for 2014, 2015 and 2016, representing the top 1% of most highly cited scientists in his field. He is on the Editorial Boards of national and international journals, including Associate Editor for Psychological Medicine.